Kanker Payudara

The Full Circle of Progress: How Decades of Research Rewrote a Family’s Breast Cancer Narrative

• Patient Advocacy and Support

The Full Circle of Progress: How Decades of Research Rewrote a Family’s Breast Cancer Narrative

Ali Ikhwan October 2, 2026

In the landscape of modern oncology, the difference between a terminal diagnosis and a manageable journey is...

Read More Read more about The Full Circle of Progress: How Decades of Research Rewrote a Family’s Breast Cancer Narrative

Transforming the Landscape of Oncology: How Breast Cancer Canada is Redefining Patient-Centric Research

• Global Breast Cancer Awareness

Transforming the Landscape of Oncology: How Breast Cancer Canada is Redefining Patient-Centric Research

Neng Nana October 2, 2026

In the complex and often daunting world of oncology, the distance between a clinical diagnosis and a...

Read More Read more about Transforming the Landscape of Oncology: How Breast Cancer Canada is Redefining Patient-Centric Research

Decoding Inflammation: How Real Food Can Empower Breast Cancer Patients and Survivors

• Patient Advocacy and Support

Decoding Inflammation: How Real Food Can Empower Breast Cancer Patients and Survivors

Siti Muinah October 2, 2026

By Shelley Loving, CNE, CPC, INHC Introduction In the realm of health and wellness, few topics hold...

Read More Read more about Decoding Inflammation: How Real Food Can Empower Breast Cancer Patients and Survivors

Bridging the Health Gap: The Strategic Evolution of Philanthropic Partnership in Global Health

• Global Breast Cancer Awareness

Bridging the Health Gap: The Strategic Evolution of Philanthropic Partnership in Global Health

Nana October 2, 2026

Introduction: A New Paradigm for Global Health In an era defined by geopolitical instability, climate-driven health crises,...

Read More Read more about Bridging the Health Gap: The Strategic Evolution of Philanthropic Partnership in Global Health

The New Frontier of Oncology: How Breast Cancer Canada is Revolutionizing Patient Outcomes Through Precision Research and Digital Advocacy

• Patient Advocacy and Support

The New Frontier of Oncology: How Breast Cancer Canada is Revolutionizing Patient Outcomes Through Precision Research and Digital Advocacy

Reynand Wu October 2, 2026

TORONTO, ON – In the landscape of Canadian healthcare, few challenges are as persistent or as deeply...

Read More Read more about The New Frontier of Oncology: How Breast Cancer Canada is Revolutionizing Patient Outcomes Through Precision Research and Digital Advocacy

Bridging the Gap: How New Research into Colorado’s Biobank is Reshaping Genomic Inclusion

• Genomics and Precision Medicine

Bridging the Gap: How New Research into Colorado’s Biobank is Reshaping Genomic Inclusion

Jia Lissa October 2, 2026

In the rapidly evolving landscape of precision medicine, the promise of genomic research is often tempered by...

Read More Read more about Bridging the Gap: How New Research into Colorado’s Biobank is Reshaping Genomic Inclusion

Beyond the Checkbook: Redefining Corporate Social Responsibility Through Gifts-in-Kind

• Survivorship and Post-Treatment

Beyond the Checkbook: Redefining Corporate Social Responsibility Through Gifts-in-Kind

Rifan Muazin October 2, 2026

By Madison Decker, Charitable Advancement Manager at the National Breast Cancer Foundation (NBCF) When the modern boardroom...

Read More Read more about Beyond the Checkbook: Redefining Corporate Social Responsibility Through Gifts-in-Kind

Bridging the Genomic Gap: How GeNotes is Revolutionizing Clinical Decision Support

• Genomics and Precision Medicine

Bridging the Genomic Gap: How GeNotes is Revolutionizing Clinical Decision Support

Pevita Pearce October 2, 2026

In the rapidly accelerating era of precision medicine, the integration of genomics into routine clinical practice represents...

Read More Read more about Bridging the Genomic Gap: How GeNotes is Revolutionizing Clinical Decision Support

EASD 2026: Petrelintide pairs 10.7% weight loss with placebo-like GI tolerability

• Medical Research and Clinical Trials

EASD 2026: Petrelintide pairs 10.7% weight loss with placebo-like GI tolerability

Asep Darmawan October 2, 2026

Here’s why: Insufficient Core Content: The provided HTML snippet contains only a placeholder for premium content access,...

Read More Read more about EASD 2026: Petrelintide pairs 10.7% weight loss with placebo-like GI tolerability

Novo Nordisk Strikes Strategic Deal for Next-Gen Obesity Candidate to Challenge Lilly’s Dominance

• Treatment Innovations

Novo Nordisk Strikes Strategic Deal for Next-Gen Obesity Candidate to Challenge Lilly’s Dominance

Rifan Muazin October 2, 2026

By Jonathan Gardner Published September 29, 2026 In a high-stakes move to regain its competitive footing in...

Read More Read more about Novo Nordisk Strikes Strategic Deal for Next-Gen Obesity Candidate to Challenge Lilly’s Dominance